Walk any health IT trade show floor and you would think the hard part of healthcare AI is the AI. Smarter models, faster inference, slicker demos. But that is not where this is going to be won or lost. The technology is racing ahead. The governance behind it is not. And that gap, not the algorithms, is the real risk facing health systems right now.
Here is the uncomfortable thesis. Most hospitals are buying AI faster than they can govern it. They can sign the contract in a quarter. They cannot stand up the oversight, the validation, and the accountability in the same time. So the tools go live while the guardrails are still on a slide deck.
Consider how a typical purchase happens. A department finds a promising tool. It tests well in a demo. Leadership, under real pressure to cut costs and ease burnout, approves it. The tool starts touching clinical decisions or documentation or billing. And nobody has clearly answered the basic questions. Who validates that it works on our patient population. Who monitors it for drift. Who is accountable when it is wrong. [Author: insert a verifiable statistic on the share of health systems deploying AI without a formal governance framework, with source.]
This is not an argument against adopting AI. It is an argument that adoption without governance is borrowing trouble. A model that performs well on the vendor’s data can quietly underperform on yours. A documentation tool that is right most of the time still produces confident errors, and at scale that becomes a compliance and patient safety problem, not a rounding error.
The governance gap shows up in three places.
First, validation. Too few systems test AI tools against their own data before going live. National benchmarks are not the same as your population, your payer mix, your workflows. A tool can be genuinely good and still be wrong for you. Without local validation, you find out the hard way.
Second, monitoring. AI is not a one time install. Models drift as data and behavior change. A tool that was accurate at launch can degrade, and without active monitoring nobody notices until the errors pile up. Most organizations have no standing process to watch performance over time. [Author: cite data on AI model drift or post-deployment monitoring gaps in healthcare, with source.]
Third, accountability. When an AI assisted decision goes wrong, who owns it. The clinician who trusted the output. The vendor who built it. The administrator who bought it. If the answer is unclear before deployment, it will be very clear and very expensive afterward, in court if not in committee.
There is a workforce dimension that policymakers keep missing too. AI does not remove the human from healthcare operations. It moves the human up the stack, from doing the task to checking the machine that does the task. That shift needs trained people and defined roles. Cut the review layer to fund the software, and you have automated the production of errors. The savings are an illusion you pay back later.
So what does responsible adoption actually look like. It is not glamorous, and that is the point.
Validate locally before go live. Test the tool on your own data and document the result. Treat a vendor’s accuracy claim as a starting hypothesis, not a guarantee.
Monitor continuously. Assign someone to watch performance after deployment, with thresholds that trigger review. Build the dashboard before you need it.
Assign accountability in writing. Decide, before the tool touches a patient or a claim, who owns its outputs and who can pull it if it misbehaves.
Fund the human layer. The reviewers and specialists who check AI output are not overhead. They are the control system. Staff and train them like it.
Policymakers can help by pushing for standards on post deployment monitoring and transparency, the way other safety critical industries already do. Aviation does not certify an autopilot and walk away. Healthcare should not either.
The hype cycle wants us to believe the winners will be whoever buys the most advanced model. I think the opposite is true. The winners will be the systems that pair good technology with boring, disciplined governance. The losers will be the ones that mistook a fast purchase for a finished job. The algorithms are ready. The question is whether our oversight is.
About Ashok Benial
Ashok Benial is a Director at AB7 Solutions (Augmentive Business 7 Solutions Private Limited), which provides HIPAA-aware remote healthcare documentation, coding, and staffing support.
